SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-020169
Filing Date
2024-05-16
Accepted
2024-05-16 13:34:37
Documents
1
Period of Report
2024-03-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4001
  Complete submission text file 0001493152-24-020169.txt   5672
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CV SCIENCES, INC. 2688 S. RAINBOW BLVD., SUITE B LAS VEGAS NV 89146
Business Address
MCNULTY JAMES A (Reporting) CIK: 0001275857 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 24954479